NCT02498171

Brief Summary

This study is aimed at evaluating single short spinal technique as a form of labour analgesia in a setting where more expensive and labor intensive techniques are not feasible.The study will examine the safety and efficacy of two drug combinations (intrathecal morphine+fentanyl vs intrathecal morphine+bupivacaine) through a randomized control trial. The investigators hypothesize that a single shot of either intrathecal morphine plus fentanyl or intrathecal morphine plus bupivacaine achieve analgesia and are safe in parturients experiencing normal labour.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
138

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2014

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2014

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

July 7, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 15, 2015

Completed
Last Updated

July 15, 2015

Status Verified

July 1, 2015

Enrollment Period

2 months

First QC Date

July 7, 2015

Last Update Submit

July 12, 2015

Conditions

Keywords

Labour analgesiaIntrathecal morphineBupivacaineFentanyl

Outcome Measures

Primary Outcomes (1)

  • Duration of analgesia

    Monitoring the level of pain by the visual analogue scale to determine the total duration of analgesia in hours starting 5 min after drug administration

    10 hours

Secondary Outcomes (2)

  • APGAR score

    6 minutes

  • Maternal side effects (composite)

    34 hours

Other Outcomes (2)

  • Degree of satisfaction

    24 hours after delivery

  • Time of onset of analgesia

    After drug administartion

Study Arms (2)

Intrathecal morphine with fentanyl

EXPERIMENTAL

Single shot of intrathecal morphine 100mcg mixed with 25mcg of fentanyl and filled up to make a 2ml solution. This would then be injected into the subarachnoid space through L2-3 or L3-4 following standard procedures.

Drug: Intrathecal morphine with fentanyl

Intrathecal morphine with bupivacaine

ACTIVE COMPARATOR

Single shot of intrathecal morphine 100mcg mixed with 2.5mg of spinal bupivacaine and filled up to make a 2ml solution.This would then be injected into the subarachnoid space through L2-3 or L3-4 following standard procedures.

Drug: Intrathecal morphine with bupivacaine

Interventions

Parturients in this arm underwent a single shot spinal following standard procedure. the drug mixture was then introduced into the subarachnoid space following free flow of csf. the parturient was the monitored fo labour progression using the standard partogram, vital signs and the visual analogue scale score for pain recorded every 5 min. The fetus was monitored with an ultrasonic aided fetal Doppler until delivery

Also known as: Morphine Sulphate 10mg/ml, Ampoule 1ml,Martindale Hong Kong, Fentanyl Citrate 0.05mg/ml, Ampoule 2ml,Martindale Hong Kong
Intrathecal morphine with fentanyl

Parturients in this arm underwent a single shot spinal following standard procedure. the drug mixture was then introduced into the subarachnoid space following free flow of csf. the parturient was the monitored fo labour progression using the standard partogram, vital signs and the visual analogue scale score for pain recorded every 5 min. The fetus was monitored with an ultrasonic aided fetal Doppler until delivery

Also known as: Morphine Sulphate 10mg/ml, Ampoule 1ml, Martindale Hong Kong, sesorcaine 0.5%, Ampoule 4ml, Astrazeneca
Intrathecal morphine with bupivacaine

Eligibility Criteria

Age14 Years - 60 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Parturients with singleton pregnancy
  • Emancipated minors

You may not qualify if:

  • Those who declined.
  • Parturients with any identified complication of labour like preeclampsia, severe cardiac disease or previous operative delivery.
  • Sepsis or wound at site of spinal injection.
  • Allergy to any of the study drugs elicited from history.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Decosterd I, Beggah AT, Durrer A, Buchser E. [Spinal opioids: mechanisms of action and chronic pain management]. Rev Med Suisse. 2006 Jun 21;2(71):1636-8, 1640. French.

  • Cascio M, Pygon B, Bernett C, Ramanathan S. Labour analgesia with intrathecal fentanyl decreases maternal stress. Can J Anaesth. 1997 Jun;44(6):605-9. doi: 10.1007/BF03015443.

  • Fontaine P, Adam P, Svendsen KH. Should intrathecal narcotics be used as a sole labor analgesic? A prospective comparison of spinal opioids and epidural bupivacaine. J Fam Pract. 2002 Jul;51(7):630-5.

MeSH Terms

Conditions

Labor Pain

Interventions

FentanylMorphineBupivacaine

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

PiperidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsMorphine DerivativesMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingPhenanthrenesPolycyclic Aromatic HydrocarbonsPolycyclic CompoundsAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • Andrew Kintu, M.med

    Department of Anesthesia and Critical Care, Makerere University, College of Health Sciences, Kampala,Uganda

    STUDY DIRECTOR
  • Timothy Muyimbo, M.med

    Department of Anesthesia and Critical Care, Makerere University, College of Health Sciences, Kampala,Uganda

    PRINCIPAL INVESTIGATOR
  • Fred Bulamba, M.med

    Department of Anesthesia and Critical Care, Makerere University, College of Health Sciences, Kampala,Uganda

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 7, 2015

First Posted

July 15, 2015

Study Start

January 1, 2014

Primary Completion

March 1, 2014

Study Completion

March 1, 2014

Last Updated

July 15, 2015

Record last verified: 2015-07